ASEAN Harmonisation TM & HS Registration 2012
-
Upload
asian-food-regulation-information-service -
Category
Education
-
view
964 -
download
0
description
Transcript of ASEAN Harmonisation TM & HS Registration 2012
ASEAN Harmonization on Traditional Medicine and Health Supplement
Registration Requirement
N. BUNYAPRAPHATSARA
ASEAN
2
• Brunei• Indonesia• Malaysia• Philippines• Singapore• Thailand
• Cambodia• Laos• Myanmar• Vietnam
ASEAN Political – Security Community(APSC)
ASEAN Economic Community (APEC)
ASEAN Socio – Cultural Community (ASCC)
3
AEC
• Single market and production base• Accelerating regional integration• Facilitating movement of business
persons, skill labours and talents• Strengthening the institutional
mechanisms of ASEAN
4
Single Market and Production Base
• Free flow of goods• Free flow of services • Free flow of investment• Free flow of capital• Free flow of skilled labours• Priority integration sectors• Food, agriculture and forestry
5
Free Flow of Goods
• Tariff• Non tariff barrier• Custom integration• ASEAN single window• Standard and technical barriers to trade
6
ASEAN Module for TMHS
• Harmonization of technical requirement• ATSC (ASEAN THMS Scientific Committee)
7
TMHS Claims
• TM Claims Framework• HS Claims Framework
8
Key Principles• Be consistent with the ASEAN working definition of TM
and HS• Enable consumers to make an informed choice
regarding products• Not be misleading or false• Support the safe, beneficial and appropriate use of the
products• Maintain the level of traditional usage and/ or scientific
evidence which is proportionate to the type of claims• Meet the dosing recommendations stated in the
evidence or references for the claimed intended effects, if applicable
9
• Be for health maintenance and promotion purpose, where the product is a HS
• Not be medicinal or therapeutic in nature, such as implied for treatment, cure or prevention of diseases, where the product is a HS
• Be for health maintenance and treatment of disease in according to traditional principles and practice, where the product is a TM
Key Principles (cont.)
TM Claims
• Treatment• Prevention• Relief of symptoms
of diseases
11
Types of Claims
• Traditional health use claims• Traditional treatment claims• Scientifically established treatment
claims
12
• Type of TM claims I : Traditional Health Use
• Level of evidence: Evidence from documented traditional use and knowledge
• Criteria for well-documented accepted TM claims – Claims for general health maintenance or enhancement are
documented in authoritative TM reference– In accordance to TM principles and practice– Adhere to the key principles ASEAN TM/HS claims
Evidence to substantiate TM Claims I
Total of 1 or more
• Document traditional or history of use• Classical TM texts• Authoritative reference texts• Recommendations or approval on claims usage
from authority or reputable organizations recognized by ASEAN THMS
14
• Type of TM claims II : Traditional Treatment
• Level of evidence: Evidence from documented traditional treatment
• Criteria for well-documented accepted TM claims – Claims for treatment and prevention are documented in
authoritative TM references– In accordance with TM principles and practice– Adheres to the key principles of ASEAN TM/ HS claims
Evidence to substantiate TM Claims II
Total of 2 or more
• Documented traditional or history of use• Classical TM texts• Authoritative reference texts• Recommendations or approval on claimed
usage from authority or reputable organization reorganization recognized by ASEAN TMHS
16
• Type of TM claims III : Scientifically Established Treatment
• Level of evidence: Scientific data and TM principles
• Criteria for well-documented accepted TM claims – Claims for treatment are approved by a recognized regulatory
authority based on human intervention studies– In line with TM principles– Adheres to the key principles
Evidence to substantiate TM Claims III
Total of 2 or more
Compulsory evidence• Scientific evidence from human studies (intervention) on
TM ingredient or productAt least 1 additional evidence• Documented traditional or history of use• Authoritative reference texts• Recommendations or approval on claimed usage from
authority or reputable organized by ASEAN member states
• Authoritative TM clinical practice reference texts• Scientific evidence from animal studies
18
HS Claims
• General or Nutritional• Functional• Disease risk reduction
19
• Type of HS claims I : General or Nutritional
• Level of evidence : General
• Criteria for well-documented acceptable HS claims– The claims is related to human in line with scientific or
traditional knowledge– Documented in authoritative reference texts– Recognized by reputable or international
organizations or regulatory authorities– Claim is not referring to structure and function of body– Adheres to the key principles of ASEAN TM/HS
claims
20
Evidence to substantiate HS Claim I
Total of 1 or more of the following evidence– Authoritative reference texts– Recommendation from reputable/ international
organizations or approval, where applicable, from regulatory authorities
– Documented history of use
21
• Type of HS claims II : Functional
• Level of evidence : Medium
• Criteria for Well-documented acceptable HS Claims– Functional claim is in line with established knowledge
on nutrition and physiology– Documented in authoritative reference texts– Recognized by reputable or international
organizations or regulatory authorities– Adheres to the key principles of ASEAN TM/HS
claims
22
Evidence to substantiate HS Claim II
At least 1compulsory evidence:• Good quality scientific evidence from human
observational studies (in the event that human study is not feasible, animal studies shall only be acceptable together with other scientific literature and documented traditional use)
• Authoritative reference texts• Recommendations from reputable/ international
organization or approval, where applicable, from recognized regulatory authorities
23
Evidence to substantiate HS Claim II (cont.)
At least 1 additional evidence • Scientific evidence from animal studies• Documented history of use• Evidence from published scientific review
24
• Type of HS claims III : Disease risk reduction
• Level of evidence : High
• Criteria for Well-documented acceptable HS Claims– The relationship between the HS ingredient or
product and disease risk reduction is supported by consistent scientific evidence
– Documented in authoritative reference texts– Recognized by reputable or international
organizations or regulatory authorities– Adheres to key principle of ASEAN TM/HS claims
25
Evidence to substantiate HS Claim III
Total of 2 or more of the following evidenceCompulsory evidence• Scientific evidence from human intervention study
on ingredient or productAt least 1 additional evidence:• Authoritative reference texts• Recommendations from reputable/ international
organizations or approval, when applicable, from regulatory authorities
• Evidence from published scientific reviews or meta-analysis
26
Safety of TMHS
• Toxicity data not required for– TM with long history of safe use– HS which has been consumed as food or food
constituents within the usage limit
27
Toxicity Data Required for
a. New ingredients/ substancesb. Ingredients/ substances/ derived from
new methods of purification or extraction/ manufacturing
c. Existing ingredients/ substances/ products with new applications
d. Existing ingredients/ substances with safety concern
28
Data Required
• Overview of available safety information/ knowledge
• Summary of toxicity/ safety papers available
• Toxicity safety study requirement
29
TMHS Ingredient/ Substances/ Products defined under a,b & c
Assessment on safety available3.1 Safety overview on available data/ knowledge3.2 Literature review of published toxicity/ safety paper available
Sufficient safetyData obtained from 3.1 & 3.2
Insufficient safety Data from 3.1 & 3.23.3 Toxicity study requirements (company owned data)
a. New Ingredient/ Substances
b. New MethodsIngredient/ substances derived from new methods of purification or extraction
c. New UsagesExisting ingredient/ products with new usages in term of composition, dosage form, usages/ indication, route of administration, special target population e.g. pregnant women, children, etc.)
Sub-chronic and/ or chronic toxicity and/ or other toxicity studies are required, if applicable
Sub-chronic or chronic toxicity studies are required, if applicable
Toxicity study should be conducted in accordance to its usages on a case by case basis. 30
Restricted List of Active Substances for THMS
• Aconitum Carmichael• Bufo kusnezaffii• Berberis app
etc.
31
Stability Study & Shelf-life
• Guideline for stability study• Accelerated stability data (6 months)• Real time stability study (2 years)
Study Design
• Selection of batches• Specification/ testing parameter• Testing frequency• Storage condition• Container closure system
Products Containing ingredients without known marker
• Gross organoleptic analysis• Macroscopic analysis• Microscopic analysis• Other scientific criteria
ASEAN Consultation Committee(ACCC)
• For standard and quality
35
• 3 Working groups• 8 Product working group
36
ASEAN Consultative Committee forStandards and Quality (ACCSQ)
Core Activities
• Standards and technical requirements• Technical regulations• Conformity assessment procedures
37
TMHS
• GMP– Raw material– In – process control– Products
38
Positive Impact
• Economic impact– Be able to compete with other regions
• Social impact– Consumers protection
Negative Impact
• SMEs– Large investment for improving– Several studies to support the claims & safety– Stability studies
Thank You